Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9893 USD | -1.07% |
|
-20.22% | -56.03% |
06-13 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
06-10 | Vor Biopharma Inc. Announces Management Appointments, Effective June 21, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.03% | 67.53M | |
+16.59% | 44.44B | |
-9.89% | 37.99B | |
+38.08% | 37.75B | |
+27.12% | 30.78B | |
-8.64% | 27.38B | |
+11.81% | 26.17B | |
+45.08% | 14.15B | |
+32.85% | 12.59B | |
-7.19% | 11.28B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Barclays Adjusts Vor Biopharma's Price Target to $26 From $56; Overweight Rating Kept